Back
Alnylam Pharmaceuticals Vs. Doximity Industry Stock Comparison
Sell
38
ALNY
Alnylam Pharmaceuticals
Last Price:
269.03
Seasonality Move:
10.72%
Buy
72
DOCS
Doximity
Last Price:
58.08
Seasonality Move:
-1.56%
Sell
38
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $279.82. The Score for ALNY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
72
Doximity (DOCS)
is a Buy
Is Doximity a Buy, Sell or Hold?
- The current Doximity [DOCS] share price is $61.25. The Score for DOCS is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
- DOCS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $279.82
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.85 | Sell |
| Relative Strength Index (14 RSI): | 51.4 | Buy |
| Chaikin Money Flow: | -260944 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (271.02 - 291.54) | Sell |
| Bollinger Bands (100): | (240.94 - 285.06) | Buy |
DOCS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.76 | Buy |
| Relative Strength Index (14 RSI): | 88.77 | Buy |
| Chaikin Money Flow: | 3535937 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (39.16 - 48.72) | Buy |
| Bollinger Bands (100): | (28.75 - 43.25) | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 272.29 | Buy |
| 20-day SMA: | 283.03 | Sell |
| 50-day SMA: | 273.82 | Buy |
| 200-day SMA: | 208.32 | Buy |
| 8-day EMA: | 276.01 | Buy |
| 20-day EMA: | 278.02 | Buy |
| 50-day EMA: | 273.01 | Buy |
| 200-day EMA: | 229.43 | Buy |
DOCS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 46.64 | Buy |
| 20-day SMA: | 44.02 | Buy |
| 50-day SMA: | 41.92 | Buy |
| 200-day SMA: | 31.55 | Buy |
| 8-day EMA: | 49.3 | Buy |
| 20-day EMA: | 45.39 | Buy |
| 50-day EMA: | 41.86 | Buy |
| 200-day EMA: | 33.99 | Buy |
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.48 per share, and an increase next year of $0.66 per share.
Doximity Earnings Growth & DOCS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.25 per share.
Alnylam Pharmaceuticals Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Doximity Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||